Assessment of the diagnostic performances of IgA heavy and light chain pairs in patients with IgA monoclonal gammopathy
- 3 October 2012
- journal article
- research article
- Published by Elsevier BV in Clinical Biochemistry
- Vol. 46 (1-2), 79-84
- https://doi.org/10.1016/j.clinbiochem.2012.09.023
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Novel M-Component Based Biomarkers in Waldenström's MacroglobulinemiaClinical Lymphoma Myeloma and Leukemia, 2011
- Isotype-Specific Heavy/Light Chain (HLC) Suppression as a Predictor of Myeloma Development in Monoclonal Gammopathy of Undetermined Significance (MGUS).Blood, 2009
- Heavy/Light Chain Specific Immunoglobulin Ratios at Presentation Are Prognostic for Progression Free Survival in the IFM 2005-01 Myeloma Trial.Blood, 2009
- Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin κ/λ RatiosClinical Chemistry, 2009
- Quantitation of Serum Monoclonal Proteins: Relationship between Agarose Gel Electrophoresis and ImmunonephelometryClinical Chemistry, 2009
- Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2008
- Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration RateAnnals of Internal Medicine, 2006
- International uniform response criteria for multiple myelomaLeukemia, 2006
- Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceBlood, 2005
- Highly Sensitive, Automated Immunoassay for Immunoglobulin Free Light Chains in Serum and UrineClinical Chemistry, 2001